Skip to main content

Table 3 Multivariate predictors for incidence of metachronous cancers after head and neck cancer

From: Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer

 

All cancers

Esophageal cancer

Lung cancer

Other cancers

OR

95%CI

P value

OR

95%CI

P value

OR

95%CI

P value

OR

95%CI

P value

Age

< 65 years

1.20

0.95–1.52

0.131

1.75

1.27–2.41

< 0.001

0.84

0.50–1.39

0.492

0.89

0.65–1.22

0.465

≥65 years

1

  

1

     

1

  

Sex

Male

1.32

0.94–1.87

0.129

1.20

0.69–1.74

0.697

2.02

0.78–5.22

0.149

1.65

0.99–2.72

0.051

Female

1

  

1

  

1

  

1

  

Histological type

Squamous cell carcinoma

3.63

1.30–10.1

0.014

7.50

1.02–55.2

0.048

   

2.17

0.67–7.05

0.196

Others

1

  

1

  

Not applicablea

1

  

Lesion location

Oral cavity

1

  

1

  

1

  

1

  

Oropharynx

1.08

0.68–1.72

0.731

1.40

0.72–2.71

0.325

0.33

0.07–1.56

0.162

0.88

0.50–1.57

0.669

Hypopharynx

3.17

2.25–4.48

< 0.001

5.88

3.62–9.55

< 0.001

2.47

1.13–5.42

0.024

1.20

0.76–1.88

0.439

Larynx

1.92

1.34–2.74

< 0.001

1.53

0.88–2.68

0.132

2.14

0.97–4.73

0.061

1.42

0.91–2.20

0.122

  1. OR Odds ratio, CI confidence interval
  2. aHistological type was excluded from the multivariate analysis for metachronous lung cancer which developed only in patients with head and neck squamous cell carcinoma